These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 506082)

  • 1. [Treatment of spastic disorders of the bronchopulmonary tract with salbutamol tablets].
    Kandus J
    Vnitr Lek; 1979 Aug; 25(8):797-803. PubMed ID: 506082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the bronchodilator action of salbutamol and orciprenaline by aerosol administration in patients with chronic bronchopneumopathy].
    Sorbini CA; Todisco T; Boschetti E
    Minerva Med; 1976 Mar; 67(16):1079-83. PubMed ID: 1264384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
    Iaia E; Cagnazzo R; Digilio VS; Scoditti A
    Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
    [No Abstract]   [Full Text] [Related]  

  • 4. [Salbutamol in children with CARA; a comparison of administration with tablets and with the Rotahaler].
    van der Ploeg RJ; Tolhoek HJ; Akkerboom JC; Knol K
    Tijdschr Kindergeneeskd; 1981 Jun; 49(3):92-9. PubMed ID: 7302939
    [No Abstract]   [Full Text] [Related]  

  • 5. [Respiratory, cardiological and metabolic functional studies of the effects of salbutamol in bronchopathic patients of various ages].
    Babolini G; Gemelli M; Capone M; Coglitore G; Ministeri S; Girbino G; Pinizzotto G; Barberio G
    Minerva Med; 1976 Mar; 67(16):1058-66. PubMed ID: 1264381
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dosage of salbutamol in spastic bronchitis in the 1st 2 years of life].
    Bignante T; De Biaggi R; De Candussio G
    Minerva Pediatr; 1977 Mar; 29(7):467-9. PubMed ID: 865420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prolonged use of salbutamol syrup in 25 aged patients].
    Wemeau J; Bonniere B
    Lille Med; 1979 Mar; 24(3):250-2. PubMed ID: 491832
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of orally administered Salbutamol (Ventolin) and orciprenaline in patients with reversible bronchospasm].
    Müller J; Zieliński J
    Gruzlica; 1973 Nov; 41(11):1155-62. PubMed ID: 4765796
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of salbutamol in patients with chronic obstructive lung disease (author's transl)].
    Pasquis P; Nouvet G; Denis P; David P; Lefrançois R; Morère P
    Therapie; 1981; 36(1):81-5. PubMed ID: 7233376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravenous salbutamol in the treatment of bronchial spasm].
    Mariotta S; Pasqua F; Mannino F
    Minerva Med; 1978 Jan; 69(4):257-60. PubMed ID: 342989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ambulatory care of obstructive ventilation disorders with salbutamol].
    Hofmann AC
    Fortschr Med; 1972 May; 90(14):559-61. PubMed ID: 5072278
    [No Abstract]   [Full Text] [Related]  

  • 14. [New developments in the field of bronchospasmolytics].
    Nolte D
    Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experimentation with salbutamol in bronchial obstructive diseases of early infancy].
    Picchioni P; Minelli P
    Minerva Pediatr; 1977 Feb; 29(5):311-4. PubMed ID: 323678
    [No Abstract]   [Full Text] [Related]  

  • 16. Bronchospasm: prevention and treatment.
    Ghiringhelli P
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):52-5. PubMed ID: 2859254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Salbutamol in the treatment of functional broncho-obstructive syndromes].
    Fiora L
    Minerva Med; 1976 Apr; 67(17):1165-75. PubMed ID: 1264395
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled powder and aerosol salbutamol in metacholine-induced bronchial obstruction.
    Lahdensuo A; Sovijärvi A; Muittari A
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():515-7. PubMed ID: 6352312
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of orally administered salbutamol in the relief of bronchospasm in bronchial asthma.
    Guleria JS; Batra GK; Gupta SP; Pande JN
    South Med J; 1974 Nov; 67(11):1337-41. PubMed ID: 4610770
    [No Abstract]   [Full Text] [Related]  

  • 20. [The broncholytic effect of salbutamol inhalation].
    Gonsior E; Thiel C; Schultze-Werninghaus G; kroidl R
    Ther Ggw; 1974 Oct; 113(10):1727-38. PubMed ID: 4467324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.